Phase II Study of a Liposome-Entrapped Cisplatin Analog (L-NDDP) Administered Intrapleurally and Pathologic Response Rates in Patients With Malignant Pleural Mesothelioma

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

2003 • 2,871 citations

The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

1961 • 685 citations

Modified RECIST criteria for assessment of response in malignant pleural mesothelioma

2004 • 614 citations

A Proposed New International TNM Staging System for Malignant Pleural Mesothelioma

1995 • 602 citations

Analysis of Current Trends in United States Mesothelioma Incidence

1997 • 279 citations

Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B₁₂ as Front-Line Therapy in Malignant Pleural Mesothelioma

2003 • 260 citations

The epidemiology of mesothelioma

2002 • 188 citations

A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.

1994 • 181 citations

Demographic Patterns for Mesothelioma in the United States

1987 • 172 citations

Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma

1998 • 123 citations

Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II).

1990 • 113 citations

Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion

2001 • 81 citations

GENE THERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA

1998 • 75 citations

Multimodality treatment of diffuse malignant pleural mesothelioma

2002 • 74 citations

Liposomes as carriers of antitumor agents: Toward a clinical reality

1989 • 61 citations

Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles.

1987 • 57 citations

Chemotherapy for malignant mesothelioma: From doxorubicin to vinorelbine

2002 • 53 citations

Chemotherapy for Malignant Pleural Mesothelioma

2003 • 52 citations

Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: The ucla experience

1995 • 50 citations

Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.

1997 • 47 citations

Increased cytotoxicity and reversal of resistance to cis-diamminedichloro-platinum(II) with entrapment of cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) in multilamellar lipid vesicles.

1988 • 45 citations

Surgery Followed by Intracavitary plus Systemic Chemotherapy in Malignant Pleural Mesothelioma

1996 • 41 citations

Pharmacokinetics of liposome-entrappedcis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) and cisplatin given i.v. and i.p. in the rat

1992 • 39 citations

Preclinical toxicity and pharmacology of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II)

1989 • 30 citations

Phase�I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato(trans-R, R-1, 2-diaminocyclohexane)-platinum�II entrapped in multilamellar liposome vesicles

2003 • 25 citations

Preparation and characterization of liposomes containing a lipophilic cisplatin derivative for clinical use

1994 • 17 citations

Pemetrexed: Single-agent and combination phase I study overview

2002 • 16 citations

Advances in the management of malignant mesothelioma

2003 • 15 citations

Staging and evaluating responses in malignant pleural mesothelioma

2003 • 11 citations

CME test

2002 • 1 citations